Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.

Several alternative methods to replace animal experiments have been accepted by legal bodies. An even larger number of tests are under development or already in use for non-regulatory applications or for the generation of information stored in proprietary knowledge bases. The next step for the use of the different in vitro methods is their combination into integrated testing strategies (ITS) to get closer to the overall goal of predictive "in vitro-based risk evaluation processes." We introduce here a conceptual framework as the basis for future ITS and their use for risk evaluation without animal experiments. The framework allows incorporation of both individual tests and already integrated approaches. Illustrative examples for elements to be incorporated are drawn from the session "Innovative technologies" at the 8th World Congress on Alternatives and Animal Use in the Life Sciences, held in Montreal, 2011. For instance, LUHMES cells (conditionally immortalized human neurons) were presented as an example for a 2D cell system. The novel 3D platform developed by InSphero was chosen as an example for the design and use of scaffold-free, organotypic microtissues. The identification of critical pathways of toxicity (PoT) may be facilitated by approaches exemplified by the MatTek 3D model for human epithelial tissues with engineered toxicological reporter functions. The important role of in silico methods and of modeling based on various pre-existing data is demonstrated by Altamira's comprehensive approach to predicting a molecule's potential for skin irritancy. A final example demonstrates how natural variation in human genetics may be overcome using data analytic (pattern recognition) techniques borrowed from computer science and statistics. The overall hazard and risk assessment strategy integrating these different examples has been compiled in a graphical work flow.

[1]  Jan G. Hengstler,et al.  Highlight report: towards the replacement of in vivo repeated dose systemic toxicity testing , 2011, Archives of Toxicology.

[2]  Bas J Blaauboer,et al.  The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. , 2012, ALTEX.

[3]  John D. Walker,et al.  Use of structural alerts to develop rules for identifying chemical substances with skin irritation or skin corrosion potential , 2005 .

[4]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[5]  David Kirkland,et al.  A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. , 2011, Mutation research.

[6]  Marcel Leist,et al.  Evaluation of Developmental Toxicants and Signaling Pathways in a Functional Test Based on the Migration of Human Neural Crest Cells , 2012, Environmental health perspectives.

[7]  Luis G Valerio,et al.  In silico toxicology for the pharmaceutical sciences. , 2009, Toxicology and applied pharmacology.

[8]  Changlian Zhu,et al.  Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity , 2006, The European journal of neuroscience.

[9]  Hannu Raunio,et al.  In Silico Toxicology – Non-Testing Methods , 2011, Front. Pharmacol..

[10]  M. Leist,et al.  Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. , 2012, Neurotoxicology.

[11]  Robert J Kavlock,et al.  Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Q. Meng.  Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity , 2010, Expert opinion on drug metabolism & toxicology.

[13]  David A Basketter,et al.  In vitro skin irritation: facts and future. State of the art review of mechanisms and models. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  Tanja Waldmann,et al.  Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. , 2012, Human molecular genetics.

[15]  S. Burrows,et al.  Human immunology: a case for the ascent of non‐furry immunology , 2011, Immunology and cell biology.

[16]  Thomas Hartung,et al.  The dawning of a new age of toxicology. , 2008, ALTEX.

[17]  Mitchell Klausner,et al.  Development of the EpiOcular™ Eye Irritation Test for Hazard Identification and Labelling of Eye Irritating Chemicals in Response to the Requirements of the EU Cosmetics Directive and REACH Legislation , 2011, Alternatives to laboratory animals : ATLA.

[18]  Hiroshi Yagi,et al.  Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix , 2010, Nature Medicine.

[19]  Bernhard Schölkopf,et al.  A tutorial on support vector regression , 2004, Stat. Comput..

[20]  J. Israelachvili.  The science and applications of emulsions — an overview , 1994 .

[21]  M. Leist,et al.  Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. , 2009, Toxicology and applied pharmacology.

[22]  Luna,et al.  Translation of Research Evidence From Animals to Humans , 2006 .

[23]  Chihae Yang,et al.  Mechanistic study of model monolayer membranes and their interactions with surfactants: correlation , 2001 .

[24]  Jan G Hengstler,et al.  Compound selection for in vitro modeling of developmental neurotoxicity. , 2012, Frontiers in bioscience.

[25]  Kurt Hornik,et al.  Support Vector Machines in R , 2006 .

[26]  George Loizou,et al.  Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  Ricarda Thier,et al.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine , 2003, International archives of occupational and environmental health.

[28]  Marcel Leist,et al.  Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  T. Hartung.  Thoughts on limitations of animal models. , 2008, Parkinsonism & related disorders.

[30]  Jeppe Falsig,et al.  Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95‐driven apoptosis , 2003, Journal of neurochemistry.

[31]  Luis G Valerio,et al.  In silico toxicology models and databases as FDA Critical Path Initiative toolkits , 2011, Human Genomics.

[32]  Marcel Leist,et al.  Metabolic Depletion of Atp by Fructose Inversely Controls Cd95- and Tumor Necrosis Factor Receptor 1–Mediated Hepatic Apoptosis , 2000, The Journal of experimental medicine.

[33]  Marcel Leist,et al.  GFAP‐independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells , 2012, Glia.

[34]  Thomas Hartung,et al.  Food for Thought ... on mapping the human toxome. , 2011, ALTEX.

[35]  M. Leist,et al.  Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite* , 2010, The Journal of Biological Chemistry.

[36]  Martin Fussenegger,et al.  Microscale tissue engineering using gravity-enforced cell assembly. , 2004, Trends in biotechnology.

[37]  Robin A Felder,et al.  3D cell culture opens new dimensions in cell-based assays. , 2009, Drug discovery today.

[38]  J. Bailar,et al.  Toxicity testing in the 21st century—a vision and a strategy , 2012 .

[39]  P. Desmond,et al.  Introduction of lamivudine for the treatment of chronic hepatitis B: Expected clinical and economic outcomes based on 4‐year clinical trial data , 2002, Journal of gastroenterology and hepatology.

[40]  Karl-Heinz Krause,et al.  The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.

[41]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[42]  Thomas B Knudsen,et al.  Zebrafish: as an integrative model for twenty-first century toxicity testing. , 2011, Birth defects research. Part C, Embryo today : reviews.

[43]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[44]  Jenny Karlsson,et al.  Additive Effects of Caspase Inhibitor and Lazaroid on the Survival of Transplanted Rat and Human Embryonic Dopamine Neurons , 2000, Experimental Neurology.

[45]  Wolfgang Moritz,et al.  Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. , 2011, Biotechnology journal.

[46]  A. Dietrich,et al.  Age-associated variation in sensory perception of iron in drinking water and the potential for overexposure in the human population. , 2011, Environmental science & technology.

[47]  Carl Kingsford,et al.  What are decision trees? , 2008, Nature Biotechnology.

[48]  H. Kandárová,et al.  An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. , 2009, Journal of visualized experiments : JoVE.

[49]  B. Berne,et al.  Sodium lauryl sulphate alters the mRNA expression of lipid‐metabolizing enzymes and PPAR signalling in normal human skin in vivo , 2009, Experimental dermatology.

[50]  Ruili Huang,et al.  Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting Chemicals , 2012, Environmental health perspectives.

[51]  Leif Bjermer,et al.  Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and field exercise challenge in elite cross-country skiers , 2010, British Journal of Sports Medicine.

[52]  Jeppe Falsig,et al.  Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.

[53]  Christian Beste,et al.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. , 2012, Neurotoxicology.

[54]  David M. Reif,et al.  Zebrafish developmental screening of the ToxCast™ Phase I chemical library. , 2012, Reproductive toxicology.

[55]  F. Scinicariello,et al.  The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures. , 2011, Regulatory toxicology and pharmacology : RTP.

[56]  Sebastian Hoffmann,et al.  Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.

[57]  Bas J Blaauboer,et al.  Biokinetic Modeling and in Vitro–in Vivo Extrapolations , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[58]  Tanja Waldmann,et al.  Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.

[59]  Tanja Waldmann,et al.  Extensive Transcriptional Regulation of Chromatin Modifiers during Human Neurodevelopment , 2012, PloS one.

[60]  J. Kelm,et al.  Multi-cell type human liver microtissues for hepatotoxicity testing , 2012, Archives of Toxicology.

[61]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[62]  Mardas Daneshian,et al.  Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .

[63]  Steven K. Gibb.  Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[64]  S. Kežić,et al.  Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate , 2006, Contact dermatitis.

[65]  P. Sandercock,et al.  Where is the evidence that animal research benefits humans? , 2004, BMJ : British Medical Journal.

[66]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[67]  Marcel Leist,et al.  Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  M. Leist,et al.  Food for thought... on the real success of 3R approaches. , 2008, ALTEX.

[69]  W. Koh,et al.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing , 2011, Cell Death and Differentiation.